<<

underscored material = new [bracketed material] = delete 25 24 23 22 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 BE ITENACTEDBYTHELEGISLATUREOFSTATENEWMEXICO: SAME SECTIONOFLAW. DATE; AUTHORIZINGRECONCILIATIONOFMULTIPLEAMENDMENTSTOTHE MARIJUANA DERIVATIVE;PROVIDINGFORACONTINGENTEFFECTIVE ACTIVITIES RELATINGTOPRESCRIPTIONDRUGSCONTAININGA CONTROLLED SUBSTANCESACTTOEXEMPTFROMPROSECUTIONCERTAIN RELATING TOPHARMACEUTICALS;AMENDINGASECTIONOFTHE .210154.2 and ethers,unless specificallyexempted,wheneverthe isomers, esters,ethers, salts,andsaltsofisomers, esters substances areincludedinSchedule I: Chapter 84,Section6,asamended)is amendedtoread: 53 RD LEGISLATURE SECTION 1 "30-31-6. SCHEDULEI.--Thefollowing controlled A. anyofthefollowingopiates,including their . Section30-31-6NMSA1978(being Laws 1972, -

STATE

OF SENATE BILL249 Bill B.O'Neill INTRODUCED BY

NEW AN ACT

MEXICO

- SECONDSESSION ,

2018 underscored material = new [bracketed material] = delete 25 24 23 22 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 .210154.2 possible withinthespecificchemicaldesignation: existence oftheseisomers,esters,ethersandsaltsis (23) etoxeridine; (22) etonitazene; (21) ethylmethylthiambutene; (20) ; (19) dioxaphetylbutyrate; (18) dimethylthiambutene; (17) dimepheptanol; (16) ; (15) diethylthiambutene; (14) diampromide; (13) dextrorphan; (12) ; (11) clonitazene; (10) betaprodine; (9) betamethadol; (8) betameprodine; (7) betacetylmethadol; (6) benzethidine; (5) alphamethadol; (4) alphameprodine; (3) alphacetylmethadol; (2) allylprodine; (1) acetylmethadol; - 2 underscored material = new [bracketed material] = delete 25 24 23 22 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 .210154.2 designation: salts ofisomersispossiblewithin the specificchemical exempted, whenevertheexistenceof these salts,isomersand salts, isomersandsaltsofisomers, unlessspecifically B. anyofthefollowingopiumderivatives, their (1) acetorphine; (42) trimeperidine; (41) racemoramide;and (40) properidine; (39) proheptazine; (38) ; (37) phenoperidine; (36) phenomorphan; (35) phenampromide; (34) phenadoxone; (33) norpipanone; (32) normethadone; (31) norlevorphanol; (30) noracymethadol; (29) morpheridine; (28) levophenacylmorphan; (27) levomoramide; (26) ; (25) hydroxypethidine; (24) furethidine; - 3 underscored material = new [bracketed material] = delete 25 24 23 22 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 .210154.2 specifically exempted, whenevertheexistenceofthese salts, substances, their salts, isomersandsaltsofisomers, unless that containsanyquantityofthefollowing hallucinogenic C. anymaterial,compound,mixture or preparation (22) thebacon; (21) pholcodine;and (20) normorphine; (19) ; (18) ; (17) myrophine; (16) -N-oxide; (15) morphinemethylsulfonate; (14) morphinemethylbromide; (13) methyldihydromorphine; (12) methyldesorphine; (11) ; (10) ; (9) ; (8) ; (7) ; (6) ; (5) -N-oxide; (4) codeinemethylbromide; (3) ; (2) ; - 4 underscored material = new [bracketed material] = delete 25 24 23 22 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 .210154.2 -3-(1-naphthoyl)indole; the ControlledSubstancesAct; chemical designation: isomers andsaltsofispossiblewithinthespecific (19) syntheticcannabinoids,including: (18) hashish; (17) ; (16) psilocyn; (15) psilocybin; (14) N-methyl-3-piperidylbenzilate; (13) N-ethyl-3-piperidylbenzilate; (12) peyote,exceptasotherwiseprovidedin (11) mescaline; (10) marijuana; (9) lysergicaciddiethylamide; (8) ; (7) 4-methyl-2,5-dimethoxyamphetamine; (6) dimethyltryptamine; (5) diethyltryptamine; (4) bufotenine; (3) 3,4,5-trimethoxyamphetamine; (2) 5-methoxy-3,4-methylenedioxyamphetamine; (1) 3,4-methylenedioxyamphetamine; (b) 1-butyl-3-(1-napthoyl)indole; (a) 1-[2-(4-(morpholinyl)ethyl] - 5 underscored material = new [bracketed material] = delete 25 24 23 22 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 .210154.2 cyclohexyl)-phenol; -1-naphthalenyl-methanone; and indole; -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; -9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl) 10a-tetrahydrobenzo[c]chromen-1-ol); -6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10, 1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol; -3-hydroxycyclohexyl]-phenol (CP-47,497);and5-(1, homologues: 5-(1,1-dimethylheptyl)-2-[(1R,3S) indole; (24) 3-fluoromethcathinone; and (23) 4-methoxymethcathinone; (22) 4-methylmethcathinone; (21) 3,4-methylenedioxypyrovalerone; (20) 3,4-methylenedioxymethcathinone; (k) 5-(1,1-dimethylheptyl)-2-(3-hydroxy (j) (2-methyl-1-propyl-1H-indol-3-yl) (i) 1-pentyl-3-(4-chloronaphthoyl) (h) dexanabinol,(6aS,10aS) (g) 6aR,10aR)-9-(hydroxymethyl) (f) cannabicyclohexanol(CP47,497and (e) 1-pentyl-3-(2-methoxyphenylacetyl) (d) 1-pentyl-3-(1-naphthoyl)indole; (c) 1-hexyl-3-(1-naphthoyl)indole; - 6 underscored material = new [bracketed material] = delete 25 24 23 22 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 not applyto: asScheduleIcontrolledsubstancesdoes tetrahydrocannabinols orchemicalderivativesof Control Actof1970andallotherrequirementslaw; comply withthefederalComprehensiveDrugAbusePreventionand distributes peyotetotheorganizationoritsmembersshall registration. Anypersonwhomanufacturespeyoteforor members oftheorganizationsousingpeyoteareexemptfrom religious ceremoniesbyabonafideorganization,and substance doesnotapplytotheuseofpeyoteinbonafide .210154.2 chemical derivative oftetrahydrocannabinol;and that containsmarijuana,atetrahydrocannabinol derivativeora the UnitedStatesfoodanddrugadministration hasapprovedand prescribing, storageortransportof aprescriptiondrugthat Compassionate UseAct;[and patients pursuanttotheprovisionsofLynnandErin Controlled SubstancesTherapeuticResearchActorbyqualified tetrahydrocannabinol bycertifiedpatientspursuanttothe tetrahydrocannabinols orchemicalderivativesof E. theenumerationofmarijuana, D. theenumerationofpeyoteasacontrolled F. controlledsubstances addedtoScheduleIby (1) (25) 4-fluoromethcathinone; (2) theuse,dispensing,possession, theuseofmarijuana, ] or - 7 underscored material = new [bracketed material] = delete 25 24 23 22 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 .210154.2 derivative. has approvedforthefirsttimeadrug containingamarijuana knowledge thattheUnitedStatesfood anddrugadministration legislative councilserviceimmediatelyupontheboard's New Mexicocompilationcommissionandthedirectorof marijuana derivative.Theboardofpharmacyshallnotifythe drug administrationhasapprovedoneormoredrugscontaininga legislative councilservicethattheUnitedStatesfoodand New Mexicocompilationcommissionandthedirectorof following thedatethatboardofpharmacycertifiesto effective dateoftheprovisionsthisactisthirtydays were notmadeinthesamesessionoflegislature. Section 12-1-8NMSA1978,notwithstandingthattheamendments reconciled andcompiledinaccordancewiththeprovisionsof fifty-third legislature,theprovisionsofthoseactsshallbe NMSA 1978areenactedbythefirstandsecondsessionsof RECONCILIATION.--If actsmakingamendmentstoSection30-31-6 1978." rule adoptedbytheboardpursuanttoSection30-31-3NMSA SECTION 3. SECTION 2. TEMPORARYPROVISION--COMPILATIONINSTRUCTION-- CONTINGENT EFFECTIVEDATE--NOTIFICATION.--The - 8